Alkaloids - redOrbit

News - Alkaloids

Oncothyreon Announces Presentation of PX-866 Clinical Data at American Association of Clinical Oncology Annual Meeting

2012-06-02 10:20:13

SEATTLE, June 2, 2012 /PRNewswire/ - Oncothyreon Inc.

New Drug Can Offer An Advantage In Certain Prostate Cancer Patients

2012-05-29 10:09:41

Cabazitaxel (trade name: Jevtana®) has been approved since March 2011 in men with metastatic prostate cancer who no longer respond to conventional therapy with hormone blockers and have already been pre-treated with the cytostatic drug docetaxel.

Esperance Pharmaceuticals Initiates Phase 2 Clinical Trial of its Novel Membrane-disrupting Agent, EP-100, in Patients with Advanced Ovarian Cancer

2012-05-17 10:25:26

BATON ROUGE, La., May 17, 2012 /PRNewswire/ -- Esperance Pharmaceuticals today announced that it has begun enrollment of a Phase 2, randomized, multi-center trial of EP-100 in combination

Breaking Studies: ICU Medical Inc.'s ChemoClave(TM) System Shown to Protect Nurses from Exposure to Hazardous Drugs While Increasing Nurse Satisfaction

2012-05-03 02:32:03

NEW ORLEANS, May 3, 2012 /PRNewswire-FirstCall/ -- ICU Medical, Inc.